Annotated Medicine and Device Lists
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 6.2.2 Watch group antibiotics |
Others observations: FIRST CHOICE Community acquired pneumonia (severe) SECOND CHOICE − Pharyngitis Therapeutic alternatives: erythromycin* *as second choice treatment for pharyngitis in children (EMLc only). Clarithromycin is also listed for use in combination regimens for eradication of H. pylori in adults. |
| List | Section | Observation |
|---|---|---|
| Ecuador | Essential Medicines List - Ecuador | No observations |
| WHO Model List of Essential Medicines (2021) | 6.2.2 Watch group antibiotics |
Others observations: FIRST CHOICE Community acquired pneumonia (severe) SECOND CHOICE − Pharyngitis Therapeutic alternatives: erythromycin* *as second choice treatment for pharyngitis in children (EMLc only). Clarithromycin is also listed for use in combination regimens for eradication of H. pylori in adults. |
| List | Section | Observation |
|---|---|---|
| Bolivia | LINAME 2011 - 2013 | No observations |
| Peru | 6.2.2.1 Macrolides and Lincosamides | No observations |
| Ecuador | Essential Medicines List - Ecuador | No observations |
| Chile | Essential and Prioritized Medications | No observations |
| WHO Model List of Essential Medicines (2021) | 6.2.2 Watch group antibiotics |
Others observations: FIRST CHOICE Community acquired pneumonia (severe) SECOND CHOICE − Pharyngitis Therapeutic alternatives: erythromycin* *as second choice treatment for pharyngitis in children (EMLc only). Clarithromycin is also listed for use in combination regimens for eradication of H. pylori in adults. |
| List | Section | Observation |
|---|---|---|
| Chile | Essential and Prioritized Medications | No observations |
| List | Section | Observation |
|---|---|---|
| Cuba | 6.2.4 Macrólidos y lincosamidas | No observations |